These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 19491686)

  • 1. The impact of acute myocardial infarction and stroke on health care costs in patients with type 2 diabetes in Sweden.
    Ringborg A; Yin DD; Martinell M; Stålhammar J; Lindgren P
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):576-82. PubMed ID: 19491686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology of complications and total treatment costs from diagnosis of Type 2 diabetes in Germany (ROSSO 4).
    Martin S; Schramm W; Schneider B; Neeser K; Weber C; Lodwig V; Heinemann L; Scherbaum WA; Kolb H
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):495-501. PubMed ID: 17853332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the impact of population level risk reduction in cardio-vascular disease and stroke on acute hospital admission rates over a 5 year period--a pilot study.
    Whitfield MD; Gillett M; Holmes M; Ogden E
    Public Health; 2006 Dec; 120(12):1140-8. PubMed ID: 17084425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resource use and costs of type 2 diabetes in Sweden - estimates from population-based register data.
    Ringborg A; Martinell M; Stålhammar J; Yin DD; Lindgren P
    Int J Clin Pract; 2008 May; 62(5):708-16. PubMed ID: 18355236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and incidence of Type 2 diabetes and its complications 1996-2003--estimates from a Swedish population-based study.
    Ringborg A; Lindgren P; Martinell M; Yin DD; Schön S; Stålhammar J
    Diabet Med; 2008 Oct; 25(10):1178-86. PubMed ID: 19046196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smoking as an independent risk factor for myocardial infarction or stroke in type 2 diabetes: a report from the Swedish National Diabetes Register.
    Nilsson PM; Cederholm J; Eeg-Olofsson K; Eliasson B; Zethelius B; Fagard R; Gudbjörnsdóttir S;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16(4):506-12. PubMed ID: 19561510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is fenofibrate a cost-saving treatment for middle-aged individuals with type II diabetes? An economic analysis of the FIELD Study.
    Carrington M; Stewart S
    Int J Cardiol; 2008 Jun; 127(1):51-6. PubMed ID: 17586072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of a history of diabetes on treatment and outcome in acute myocardial infarction, during two time periods and in two different countries.
    Svensson AM; Dellborg M; Abrahamsson P; Karlsson T; Herlitz J; Duval SJ; Berger AK; Luepker RV
    Int J Cardiol; 2007 Jul; 119(3):319-25. PubMed ID: 17067706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of death or acute myocardial infarction 10 years after coronary artery bypass surgery in relation to type of diabetes.
    Alserius T; Hammar N; Nordqvist T; Ivert T
    Am Heart J; 2006 Sep; 152(3):599-605. PubMed ID: 16923437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation therapy in atrial fibrillation in combination with acute myocardial infarction influences long-term outcome: a prospective cohort study from the Register of Information and Knowledge About Swedish Heart Intensive Care Admissions (RIKS-HIA).
    Stenestrand U; Lindbäck J; Wallentin L;
    Circulation; 2005 Nov; 112(21):3225-31. PubMed ID: 16301355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Economic impact of cardiovascular co-morbidity in patients with type 2 diabetes.
    Mody R; Kalsekar I; Kavookjian J; Iyer S; Rajagopalan R; Pawar V
    J Diabetes Complications; 2007; 21(2):75-83. PubMed ID: 17331855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people.
    Schramm TK; Gislason GH; Køber L; Rasmussen S; Rasmussen JN; Abildstrøm SZ; Hansen ML; Folke F; Buch P; Madsen M; Vaag A; Torp-Pedersen C
    Circulation; 2008 Apr; 117(15):1945-54. PubMed ID: 18378618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ; Martin J; Stephenson J; Kreilick C; Fernandes J; Beaulieu J; Hauch O; Kim J
    Curr Med Res Opin; 2009 Dec; 25(12):2853-64. PubMed ID: 19916729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saving lives, money and resources: drug and CABG/PCI use after myocardial infarction in a Swedish record-linkage study.
    Wilhelmsen L; Welin L; Odén A; Björnberg A
    Eur J Health Econ; 2010 Apr; 11(2):177-84. PubMed ID: 19495819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retrospective analysis of cardiovascular outcomes in patients with type 2 diabetes mellitus after the first acute myocardial infarction.
    Moejko-Pastewka B; Tatoń J; Haczyński J; Strojek K; Ametov AS; Milicevic Z
    Acta Diabetol; 2003 Dec; 40 Suppl 2():S354-7. PubMed ID: 14704868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A; Spannheimer A; Reitberger U; Görtz A
    Med Klin (Munich); 2002 Dec; 97(12):713-9. PubMed ID: 12491064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of rosuvastatin use on costs and outcomes in patients at high risk for cardiovascular disease in US managed care and medicare populations: A data analysis.
    Huse DM; Song X; Ozminkowski RJ; Maguire J; Williams SA; Borok GM; McDonough K
    Clin Ther; 2006 Sep; 28(9):1425-42. PubMed ID: 17062315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication adherence and the associated health-economic impact among patients with type 2 diabetes mellitus converting to insulin pen therapy: an analysis of third-party managed care claims data.
    Lee WC; Balu S; Cobden D; Joshi AV; Pashos CL
    Clin Ther; 2006 Oct; 28(10):1712-25; discussion 1710-1. PubMed ID: 17157128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence rates of heart failure, stroke, and acute myocardial infarction among Type 2 diabetic patients using insulin glargine and other insulin.
    Juhaeri J; Gao S; Dai WS
    Pharmacoepidemiol Drug Saf; 2009 Jun; 18(6):497-503. PubMed ID: 19326365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.